Kornfield, Rachel <br/><br/>
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008.  [electronic resource] 

 -  Psychiatric services (Washington, D.C.)  Apr 2013 
 - 339-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1557-9700 
<br/><br/><label>Standard No.: </label>10.1176/appi.ps.201200147  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adrenergic Uptake Inhibitors--therapeutic use<br/>Adrenergic alpha-2 Receptor Agonists--therapeutic use<br/>Amphetamines--therapeutic use<br/>Atomoxetine Hydrochloride<br/>Attention Deficit Disorder with Hyperactivity--drug therapy<br/>Bupropion--therapeutic use<br/>Central Nervous System Stimulants--therapeutic use<br/>Child<br/>Clonidine--therapeutic use<br/>Dopamine Uptake Inhibitors--therapeutic use<br/>Drug Utilization<br/>Guanfacine--therapeutic use<br/>Humans<br/>Practice Patterns, Physicians'--statistics & numerical data<br/>Propylamines--therapeutic use<br/>United States<br/>United States Food and Drug Administration